Software P pharmaphorum
AI and pharma launch - Within3’s Jason Smith
AI and pharma launch - Within3’s Jason Smith Nicole.Raleigh Tue, 06/10/2026 - 10:44
The latest biotech and pharma news from the trade press, updated every hour and linked straight to the publisher. Follow funding, clinical, deals and more. Every story links straight to its publisher.
Software P pharmaphorum
AI and pharma launch - Within3’s Jason Smith Nicole.Raleigh Tue, 06/10/2026 - 10:44
Clinical
European Biotechnology
Genmab and AbbVie's bispecific antibody epcoritamab, added to R-CHOP chemoimmunotherapy, cut the risk of progression or death by 51% in a Phase 3 trial in newly diagnosed diffuse large B-cell lymphoma (DLBCL). The post Genmab and AbbVie’s bispecific antibody halves progression-or…
Industry
Pharmaceutical Technology
Lilly is continuing to bet on the molecular gate approach, which Gate says could create therapies targeting hard-to-drug proteins.
Software T The Labs Report
Most conversational AI can follow what you say, but struggles with what you need. At iris labs, the goal is to build AI with the emotional intelligence to respond in ways that help people flourish.
Industry P pharmaphorum
Beyond Market Access: Why healthcare-system understanding is becoming a leadership capability Nicole.Raleigh Tue, 06/10/2026 - 10:30
Software M Mac in Chem
UK registered micro, small or medium sized enterprise (SMEs) can apply for a share of up to £3.1 million to deliver feasibility studies for frontier
Regulatory A Applied Clinical Trials
In today's ACT Brief, we examine FDA input sought on early-phase ibogaine protocols, why mixed outsourcing models spread faster than oversight infrastructure, and a major partnership for a rare kidney disease treatment.
Industry P Pharmaceutical Executive
CORXEL’s Dr. Bo Liang on why GLP-1 therapies are a broader chronic disease platform — not just obesity drugs — with benefits across cardiovascular, renal, and metabolic disease.
Clinical P Pharmaceutical Executive
Why effective RWD linkage starts with a specific research objective — and how tokenization, clean rooms, and AI make it possible.
Industry
Pharmaceutical Technology
Alector’s approach combines an engineered GCase with the biotech’s blood-brain barrier delivery platform.
Industry
Pharmaceutical Technology
CSL and Alentis will work together to progress antifibrotic drug, lixudebart across multiple rare kidney and liver diseases.
Industry
Pharmaceutical Technology
Pacira BioSciences has entered into an exclusive agreement with Italian pharmaceutical company Molteni Farmaceutici to distribute and commercialise Exparel across the EU and the UK.
Clinical
Clinical Trials Arena
AbbVie and Genmab have reported positive topline data from the Phase III EPCORE DLBCL-2 trial of epcoritamab combined with standard R-CHOP in newly diagnosed DLBCL patients. The post AbbVie, Genmab report positive results from Phase III EPCORE DLBCL-2 trial appeared first on Clin…
Clinical P Pharmafile
Boehringer Ingelheim’s investigational survodutide produced weight loss of up to 13.1% after 76 weeks in people with obesity or overweight and type 2 diabetes (T2D), while also improving glycaemic control in the phase 3 SYNCHRONIZE-2 trial. The trial met its co-primary endpoints,…
Industry B BioTechniques
Original story from Eötvös Loránd University (Budapest, Hungary). Dog brains segment speech into words in a way previously seen only in humans. Efficient speech processing is not necessarily a consequence of humans’ unique language abilities: regular exposure to speech alone can…
Manufacturing P Pharmafile
ESTEVE CDMO is investing a further $17.5m to expand capacity and containment capabilities at its Morton Grove facility in Illinois, taking total announced investment at the site to $33m. The latest investment, following a $15.5m programme announced earlier this year, will fund tw…
Industry P pharmaphorum
New York declares measles outbreak a "disaster emergency" Phil.Taylor Tue, 06/10/2026 - 08:33
Regulatory
STAT Biotech
“Telling more people they have cancer is not progress; progress is having fewer people die from cancer,” H. Gilbert Welch writes of Grail’s multicancer screening test.
Research E EMBL
The first EMBL in Poland event strengthened the connections between EMBL and the wider Polish life science community.
Software
European Biotechnology
AI has transformed drug discovery, but the “AI biotech” label has become increasingly misleading. Kurma Partners proposes an investment framework that distinguishes three fundamentally different models — each building a different asset, creating value in a different way and req…
Manufacturing
Labiotech
Merck’s new BioReliance® Facility in Darmstadt, Germany, will support biologics testing, GMP release testing and stability studies in Europe. The post Merck’s new BioReliance® Facility in Darmstadt: supporting biologics development and commercialization in Europe appeared first o…
Clinical
Clinical Trials Arena
Vial has dosed the first patient in its Phase Ib clinical study evaluating IL-13 x TSLP in patients diagnosed with mild-to-moderate asthma. The post First patient dosed in Vial’s Phase Ib trial of IL-13 x TSLP antibody appeared first on Clinical Trials Arena.
Industry
Pharmaceutical Technology
AstraZeneca has opened a new global strategic R&D facility in Massachusetts, US, as part of an investment of more than $1bn in the state.
Industry P pharmaphorum
Solution Spotlight: Axtria HIQ Nicole.Raleigh Tue, 06/10/2026 - 07:00
Software
European Biotechnology
France’s WhiteLab Genomics has raised $26 million (€23 million) in Series B financing to expand experimental validation of its AI-designed gene delivery technologies and build a portfolio of assets it can own and license. The post WhiteLab secures $26M to expand AI-designed gene…
Industry S Science News
Francis Halzen honored for work on IceCube Neutrino Observatory, used to discover ghostly particles from far off universe
Software
MHRA
Ministers back independent Commission's blueprint in full, while the MHRA's AI Airlock opens its next phase,
Clinical
Bio.News
One afternoon in 2024, the BIO Federal Government Affairs team received a call from Hill staff who said, “We just met the most amazing […] The post In Rare Trials Summit keynote, BIO expert highlights lives touched by PPRV appeared first on Bio.News.
Industry S Science News
Chronicle Heritage was largest U.S. cultural resources management company
Industry S Science News
Much is unclear about the tragedy, but plague researchers say there is “zero” chance of an epidemic
Industry S Science News
If Democrats win one or both chambers of Congress, investigations are likely, but meaningful change may be elusive
Industry A Applied Clinical Trials
Webinar Date/Time: Wed, Oct 28, 2026 10:00 AM EDT
Research S Science News
Agency body that funds sociology, linguistics, and archaeology studies in U.S. gave 90% fewer new grants this year
Industry F FDA Law Blog
By Andrew J. Hull & Anne K. Walsh —
Industry
BioCentury
BIOCENTURY | DEALSCHINA DEALS, BEAM LAWSUIT, MFN MODELS, NOBEL WINNERS — A BIOCENTURY PODCASTPharma partnering in China gets earlier and broader
Industry
BioCentury
BIOCENTURY | PRODUCT DEVELOPMENTSCALING UP AN INNOVATION CULTURE: A Q&A WITH ARGENX’S KAREN MASSEYHow argenx seeks to preserve entrepreneurial science as it grows
Regulatory
BioCentury
BIOCENTURY | DISCOVERY & TRANSLATIONNOBEL PRIZE FOR OPTOGENETICS ARRIVES AS FIRST THERAPY NEARS FDA DECISIONNanoscope leads direct therapeutic applications, while MapLight uses the technology to guide psychiatric drug discovery
Industry
Nature Biotechnology
Software
Nature Biotechnology
Industry N Nature Reviews Bioengineering